Browsing: News
The PrE0405 phase 2 trial met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients…
The combination of the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing spleen enlargement…
Finally, there’s good news for many of our favorite Christmas foods. A turkey meal with all the trimmings and a…
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. announced today a multi-year strategic development collaboration to…
Patients with low-risk ductal carcinoma in situ (DCIS) who omitted adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to…
Women 50 and older who stepped down to less frequent mammograms three years after treatment for early-stage breast cancer had…
SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally has not had many treatment…
UKHSA strongly encourages eligible people from ethnic minorities, particularly people from Pakistani and black Caribbean ethnic groups and people living…
An international team of researchers, including experts at the Indiana University School of Medicine, has identified a protein found in…
Angela M. Du Bois, a retired software auditor in Durham, North Carolina, didn’t want to replace the UnitedHealthcare Medicare…